87 results on '"Matsumoto, K"'
Search Results
2. Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer
3. 143P Clinical outcomes of systemic therapy for hemodialysis patients with metastatic renal cell carcinoma
4. 256P Difference of immunological status and response to immune checkpoint inhibitor between recurrent and de novo stage IV HER2-negative breast cancer in NEWBEAT trial (WJOG9917BTR)
5. 1816O A multicentre, randomized, double-blind, placebo-controlled study of olanzapine-based triplet antiemetic therapy for prevention of delayed and persistent nausea and vomiting induced by trastuzumab deruxtecan in patients with metastatic breast cancer: ERICA study (WJOG14320B)
6. 813P Efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma (STATICE trial, NCCH1615): A multicenter, phase II clinical trial
7. 277P Phase II randomized study of trimebutine maleate and probiotics for abemaciclib-induced diarrhea in patients with HR-positive and HER2-negative advanced breast cancer (MERMAID) WJOG11318B
8. 239P Elevated baseline C-reactive protein is a prognostic indicator for OS in patients with metastatic non clear cell renal cell carcinoma treated with systemic therapy
9. SRPX2 IS A NOVEL CHONDROITIN SULFATE PROTEOGLYCAN THAT IS OVEREXPRESSED IN GASTROINTESTINAL CANCER
10. FIRST-LINE CHEMOTHERAPY WITH CARBOPLATIN AND DOCETAXEL FOR ADVANCED SQUAMOUS CELL LUNG CANCER
11. CORRELATIVE STUDY OF LOW SERUM CREATININE AND HEMATOLOGICAL TOXIC EFFECTS IN JAPANESE PATIENTS WITH OVARIAN CANCER TREATED BY DOSE DENSE TC THERAPY
12. AMPLIFICATION OF OCT4-PSEUDOGENE POU5F1B IS A POOR PROGNOSTIC FACTOR IN GASTRIC CANCER
13. SELF-ASSESSMENT SYSTEM OF FEBRILE NEUTROPENIA (FN) BY PATIENTS RECEIVING AMBULATORY CHEMOTHERAPY FOR SOLID TUMOR
14. O3–053 - ORAOV1 is Amplified in Esophageal Squamous Cell Cancer and Related to Tumor Growth and Poorly Differentiated Tumor
15. O2–024 - Phase I Study of Ombrabulin in Combination with Paclitaxel + Carboplatin Administered Every 3 Weeks to Japanese Patients
16. O1–080 - The Influence of Body Mass Index on Severe Neutropenia with Dose-Dense Paclitaxel/Carboplatin in Ovarian Cancer Patients
17. O1–057 - Comt Genotype and Patients' Recognition of Pain Reduction are Predictive Markers for the Response to Morphine Treatment
18. Nivolumab treatment beyond progression disease in advanced non-small cell lung cancer
19. A novel risk-based approach simulating oncologic surveillance according to smoking status after radical nephroureterectomy with upper tract urothelial carcinoma
20. Neutrophil-to-lymphocyte ratio is a useful biomarker for predicting worse clinical outcome in chemo-resistant urothelial carcinoma patients treated with pembrolizumab
21. High intensity end-of-life care in pediatrics, adolescent and young adult patients with cancer using an administrative database
22. Association of immune-related adverse events and efficacy in Japanese patients with squamous cell carcinoma of the head and neck treated with nivolumab
23. The concordance with antiemetic guideline for pediatric, adolescent and young adult patients with cancer using a large-scale administrative database
24. 79P - Nivolumab treatment beyond progression disease in advanced non-small cell lung cancer
25. 217P - Neutrophil-to-lymphocyte ratio is a useful biomarker for predicting worse clinical outcome in chemo-resistant urothelial carcinoma patients treated with pembrolizumab
26. 209O - A novel risk-based approach simulating oncologic surveillance according to smoking status after radical nephroureterectomy with upper tract urothelial carcinoma
27. 1614P - High intensity end-of-life care in pediatrics, adolescent and young adult patients with cancer using an administrative database
28. A phase 1 study of single agent veliparib in Japanese subjects with advanced solid tumors
29. Outcomes of peri-operative chemotherapy (PO-CT) for locally advanced penile squamous cell carcinoma (LA-PSCC): results from a multicenter analysis
30. 314P - Association of immune-related adverse events and efficacy in Japanese patients with squamous cell carcinoma of the head and neck treated with nivolumab
31. 1802P - The concordance with antiemetic guideline for pediatric, adolescent and young adult patients with cancer using a large-scale administrative database
32. 351O Induction of PD-L1 expression by the EML4-ALK oncoprotein and downstream signaling pathways in non–small cell lung cancer
33. 2PD Crizotinib could overcome acquired resistance to alectinib caused by HGF autocrine in ALK rearranged non-small cell lung cancer
34. 839P - Outcomes of peri-operative chemotherapy (PO-CT) for locally advanced penile squamous cell carcinoma (LA-PSCC): results from a multicenter analysis
35. 876P - A phase 1 study of single agent veliparib in Japanese subjects with advanced solid tumors
36. Comt Genotype and Patients' Recognition of Pain Reduction are Predictive Markers for the Response to Morphine Treatment
37. The Influence of Body Mass Index on Severe Neutropenia with Dose-Dense Paclitaxel/Carboplatin in Ovarian Cancer Patients
38. ORAOV1 is Amplified in Esophageal Squamous Cell Cancer and Related to Tumor Growth and Poorly Differentiated Tumor
39. Phase I Study of Ombrabulin in Combination with Paclitaxel + Carboplatin Administered Every 3 Weeks to Japanese Patients
40. Activin-A Directly Inhibits Vascular Endothelial Cell Growth VIA TGF-b-Dependent Signal Pathway
41. Clinical Assessment of Cases of Hematological Malignancies Diagnosed by Image-Guided Needle Biopsy
42. Overexpression of FOXQ1 is Important Factor in Tumorigenecity and Tumor Growth
43. Gynecologic Cancer: Topics for Medical Treatment of Ovarian Cancer 2012
44. The Clinical Significance of Pathologic Complete Response (PCR) after Neoadjuvant Chemotherapy and Treatment Strategy in HER2 and Hormonal Receptor Positive (HR+) Breast Cancer Patients
45. A Novel Mass Spectrometry-Based Assay for Diagnosis of EML4-ALK-Positive Non-Small-Cell Lung Cancer
46. Characteristics of HS6ST2 Expression in Colorectal Cancer
47. P3-067 - Characteristics of HS6ST2 Expression in Colorectal Cancer
48. P2-169 - Clinical Assessment of Cases of Hematological Malignancies Diagnosed by Image-Guided Needle Biopsy
49. P1-016 - Activin-A Directly Inhibits Vascular Endothelial Cell Growth VIA TGF-b-Dependent Signal Pathway
50. P1-025 - First-Line Chemotherapy with Carboplatin and Docetaxel for Advanced Squamous Cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.